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Chronic prolonged sitting and consumption of high glycemic index (GI) meals are known 
to increase the risk of cardiovascular diseases. However, it is currently unknown whether 
prolonged sitting and consumption of a high GI meal have a combined negative acute effect on 
local and central arterial stiffness (AS). Therefore, 18 young, healthy participants (21.7±2.5 y, 
70% F, 25.5±6.1 kg/m2) were randomized to: 3h sitting with a high GI beverage (HGI) or a low 
GI beverage (LGI). Prolonged sitting (3 hours) and consumption of a HGI beverage increased 
central (brachial-femoral) AS, in the LGI (0.27 m/s) and the HGI (0.45 m/s) condition (p=0.027). 
Peripheral (femoral-ankle) PWV increased (0.211 m/s) regardless of the level of GI consumed. 
Carotid-femoral PWV was not influenced by prolonged sitting or HGI meal consumption. Sitting 
increases central and peripheral AS in young, healthy individuals. Consuming a HGI meal has a 
moderate detrimental effect on central (brachial-femoral) PWV. 
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CHAPTER I: INTRODUCTION 
 
Chronic sedentary behavior, defined as very low intensity behaviors (≤1.5 metabolic 
equivalents) in a seated, reclined or supine posture[122] has been directly tied to the 
development of cardiovascular disease (CVD). This is a concern because the majority of 
American adults are sitting for 70% of their day[1], and CVD cost the US $555 billion in medical 
bills, prescriptions, home-care, and other services in 2016[2]. While the chronic associations 
between repeated exposure to prolonged sitting and CVD are well known, the mechanism by 
which an acute bout of sitting leads to cardiovascular decline is less clear. Additionally, sitting is 
typically accompanied by other poor lifestyle choices, such as the consumption of high glycemic 
index (GI) meals[124]. Regular dietary exposure to high GI meals has also been linked to the 
development of CVD[66,107]. Prolonged sitting following consumption of a high GI food is 
common in today’s society[1,66]; however, the combined acute effect of both prolonged sitting 
and consumption of a high GI meal on the cardiovascular system is unclear. 
It has been shown that sitting for three hours results in decreased blood flow to the legs 
and subsequent leg endothelial dysfunction[3,4]. Current unpublished findings from our 
laboratory demonstrate that this local impairment translates to modest (0.3 m/s) central 
cardiovascular impairments, specifically increased central arterial stiffness. Additionally, high GI 
meals, which induce postprandial hyperglycemia, have been linked to an increase in arterial 
stiffness[52] and endothelial dysfunction via increased oxidative stress[46,50-51]. To date, no 
studies have investigated the combined acute effects of prolonged sitting and high GI meal 
consumption on the local and central cardiovascular system.  
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 The long-term goal from this study is to elucidate the acute effects of prolonged sitting 
and consumption of a high GI meal, which will allow for a better understanding of the 
mechanism linking these chronic exposures to CVD. This will either lead to the need for 
research of strategies to reduce the dose of sedentary behavior and high GI consumption, or a 
need for greater understanding surrounding the specific positive contributions healthy lifestyle 
choices have on “protecting” against these stimuli. While both sedentary behavior and repeated 
consumption of HGI foods are associated with metabolic, vascular, and cognition dysfunction, 
this study focused on central and peripheral vascular function, via pulse wave velocity (PWV). 
To achieve this, this study compared a HGI meal versus a low glycemic index (LGI) meal during 
a bout of 3 hours of sitting and explored the effects on central and peripheral PWV in a young, 
active, healthy population. We also looked at perfusion to the medium gastrocnemius to assess 
blood pooling in the lower extremities.  
 
Aim: To examine the acute effects of prolonged sitting with consumption of a low or high 
glycemic index meal on local and central cardiovascular health 
 Twenty healthy, young and physically active (>90 min/week) participants were recruited. 
Using a randomized cross-over design, each participant completed two conditions: prolonged 
sitting (3 hours) plus low GI meal consumption (L-GI), and prolonged sitting plus high GI meal 
consumption (H-GI). The primary outcome was central arterial stiffness (AS), and the secondary 
outcome was local (leg) arterial stiffness.  
1. Compared to L-GI, does H-GI result in greater increase in central AS? 
2. Compared to L-GI, does H-GI result in a greater increase in leg AS? 
Research Hypotheses: 
1. During prolonged sitting, H-GI will result in a greater increase in central AS. 
2. During prolonged sitting, H-GI will result in a greater increase in leg AS.  
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ASSUMPTION AND DELIMITATIONS 
 
Delimitations: 
1. Women were studied during the follicular phase of their menstrual cycle in order to 
 control for fluctuations in reproductive hormones. 
2. Participants were matched for risk factors to avoid confounding effects. 
3. All participants had similar dietary intake prior to and during both testing sessions 
4. All participants were between the ages of 18 and 35. 
5. All participants engaged in regular physical activity (>90 min/week Mod-Vig 
 intensity) 
6. Researchers encouraged no movement throughout the protocol. 
Limitations 
1. Only two NIRS probes were available for use, and were only able to measure the Hb 
in the tissue directly beneath the probe. 
2. The 3-hour protocol may have under estimated what is needed to evoke the desired 












CHAPTER II - REVIEW OF LITERATURE 
 
INTRODUCTION TO TOPIC 
Adults in the U.S. spend approximately 50-70% of their waking hours sitting[110]. The 
American workplace has seen an 83% increase in sedentary desk jobs since 1950 111]. Recent 
findings have shown that prolonged sitting is linked to vascular impairment, via endothelial 
dysfunction and arterial stiffness, and has been associated with cardiovascular diseases (CVD), 
metabolic syndrome, and all-cause mortality[3,11,72]. Additionally, the Western diet, which 
commonly includes highly refined sugars with a high GI, has been shown to increase risk for 
developing CVD[42,99].  
In order to understand the association between chronic exposure to prolonged sitting 
and high GI foods and the acute response, we need to assess the known acute effects of these 
two stimuli separately. The following review will outline the current findings in the literature 
concerning prolonged sitting and high GI meals. The effects of prolonged sitting will be broken 
down by blood flow, vascular function, and central cardiovascular effects. The effects of a high 
GI meal will be broken down by hormone response, the effect of glucose and insulin on the local 
vasculature, and central CV effects. A proposed mechanism for the combined acute effects of 
sitting and consumption of a high GI meal will then be explored (figure 1).  
CONSIDERATION 1: VASCULAR RESPONSES TO PROLONGED SITTING  
Chronic effects of prolonged sitting 
Prolonged sitting has been a topic of growing interest due to the gradual shift in our 
world’s work environment. The prevalence of sedentary behavior and increased time spent 
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sitting, common to many professions, has been associated with the development of 
CVD[3,4,17–20]. Many studies have linked chronic prolonged sitting with the development of 
type II diabetes, due to the acute effect of decreased insulin sensitivity[21]. There is now 
enough evidence to conduct meta-analyses exploring the association between sedentary time 
and disease incidence, concluding that prolonged sedentary time is independently associated 
with deleterious health outcomes regardless of physical activity[11]. More specifically, these 
deleterious health outcomes include impaired physical function[112], CVD risk-factors[113,114], 
T2DM risk-factors[115], and mortality[11,116]. 
Acute effects of prolonged sitting 
During a period of prolonged sitting, blood will pool in the lower limbs due to the lack of 
muscular contractions facilitating venous return to the heart[3,4,25]. The lack of muscle pump 
will impair the uptake of insulin by the muscle, and could lead to insulin resistance. Blood 
pooling will lead to reduced overall leg blood flow, and in turn, reduced shear stress. Since 
shear stress in a vessel is essential for maintaining endothelial health[22], impaired shear stress 
leads to impaired endothelial function. Additionally, the biomechanics of the sitting position has 
been shown to reduce shear stress by 45% when compared to straight legs in a supine 
position[4]. Overall, prolonged sitting is associated with an acute impairment in aortic shear 
stress and subsequently aortic endothelial function leading to aortic arterial stiffness, which 
could potentially lead to cardiometabolic disease in the future. 
Blood Flow 
In the context of sitting, it is known that long bouts of uninterrupted sitting leads to a 
decrease in lower limb blood flow[3]. There are several proposed mechanisms for this 
physiological response. Increased hydrostatic pressure from gravitational forces that act on the 
limb vasculature when sitting, as well as lack of venous return via muscle pump, cause blood to 
pool in the legs, which causes a decrease in total blood flow to the legs. Another proposed 
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mechanism is adrenergic vasoconstriction due to the increased muscle sympathetic nerve 
activity that is elicited in the seated position[23]. It was also theorized that circulating 
vasoconstrictor factors may increase leg vascular resistance leading to decreased blood flow[3]. 
One study found that after 6 hours of sitting, the ability of resistance vessels in the leg to 
vasodilate was impaired by 40%[3]. This suggests that nitric oxide (NO), a vasodilator, may be 
contributing to decreased lower limb blood flow. 
Vascular Function 
All blood vessels have an inner layer composed of endothelial cells that secrete nitric 
oxide (NO), among other molecules[24]. NO is secreted in response to shear stress in the 
vessel[3]. Shear stress is the force produced by blood physically moving along the endothelial 
cells and is proportional to blood flow. Shear stress contributes to endothelial health[3]. As 
shear stress increases, via increased blood flow, NO is released causing the vessel to dilate, 
which leads to increased blood flow and shear stress, maintaining endothelial health.  
Decreased shear stress has been noted as the source of vascular dysfunction during 
prolonged sitting[3,4,25]. A decrease in shear stress has been linked to the production of 
endothelin-1 (ET-1)[26]. Endothelial cells express ET-1, which leads to the formation of vascular 
reactive oxygen species, reduced NO availability, and impaired endothelium-dependent 
dilation[22,27–31]. Therefore, it is known that prolonged sitting leads to decreased blood flow to 
the legs, decreased leg vascular shear stress, impaired vasodilator abilities, and impaired 
endothelial function. However, these local impairments also translate to whole-body 
cardiovascular effects and other systems of the body due to the interaction between the 
cardiovascular system and the central nervous system and endocrine system.  
One additional measure of vascular function is arterial stiffness. Arterial stiffness (AS) 
refers to the dispensability of artery walls, determined by both structure and function of the 
vessel, and has been noted as an independent predictor of CVD[32]. Typically, AS is measured 
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in the aorta, so it is considered a measure of central cardiovascular health. AS has been shown 
to increase with sedentary behavior independent of age and disease[33], as well as after a short 
bout of sitting[34–36,108,120]. Studies have also shown that endothelial NO and shear stress 
are related to arterial stiffness (AS)[37,38]. Since AS is dependent on structure and function of 
the vessel, if endothelial function is impaired, there will be subsequent effects on AS. Therefore, 
we conclude that prolonged sitting has a negative effect on central cardiovascular health in 
addition to local vascular health. 
CONSIDERATION 2: ACUTE RESPONSES TO A HIGH GLYCEMIC INDEX MEAL 
Other lifestyle factors influence CVD disease risk, including the consumption of high 
glycemic index meals. Glycemic index (GI) quantifies the glycemic response following the 
consumption of a carbohydrate-rich food. Foods with a high GI are accompanied with an 
elevation of postprandial plasma glucose levels, rather than the gradual glucose response that 
is seen after consuming a low GI meal[42,43]. Hyperglycemia in the postprandial state has been 
linked to oxidative stress, which, in conjunction with nitric oxide (NO) synthesis disruption, leads 
to macrovascular endothelial dysfunction[44,45]. There is increasing evidence that the 
postprandial state is a contributing risk factor for the development of atherosclerosis in health 
adults[46,47].  
Hormone Responses 
Blood glucose begins to rise approximately 10 minutes after the start of a meal[47]. 
Following consumption of a high GI meal or food, blood glucose rises significantly and puts the 
body in a state of postprandial hyperglycemia. The beta cells of the pancreas respond by 
releasing insulin into the bloodstream. The release of insulin leads to the mobilization of GLUT4 
receptors from inside cells to the cellular membrane to allow for glucose uptake. The 
hyperglycemia response to a high GI meal is followed by a hypoglycemic state, due to the 
secretion of insulin by the beta cells of the pancreas, as seen in recreationally active 
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males[48,49]. This oscillation in blood glucose levels has been associated with oxidative stress 
and endothelial dysfunction[50,51], and was found to have more negative effects of endothelial 
function than constant hyperglycemia in both normal and type 2 diabetic populations[51]. 
Local cardiovascular effects from glucose 
Acute hyperglycemia has been shown to cause endothelial dysfunction within minutes or 
hours[47,53–55]. The proposed mechanism for this impaired endothelial function is that acute 
hyperglycemia increases the production of free radicals, which reduces NO availability, and 
inhibits vasodilation[53,55–57]. Endothelium-derived NO is considered the most potent 
vasodilator[58]. The production of free radicals from hyperglycemia that leads to endothelial 
dysfunction is known as oxidative stress. Oxidative stress can elicit changes in DNA, proteins, 
lipids, and give rise to various disease states[59].  
Local cardiovascular effects from insulin 
Insulin is an endothelial-dependent vasodilator in skeletal muscle vasculature[60–63]. 
This has been shown to aid in insulin-mediated glucose uptake in skeletal muscle[61,64]. When 
insulin is secreted by the beta cells of the pancreas, it facilitates blood flow to skeletal muscle 
via capillary recruitment and vasodilation to allow glucose to be taken up more readily. The 
mechanism behind insulin-mediated vasodilation is via stimulation of nitric oxide production in 
endothelial cells[65]. After the consumption of a high GI meal, postprandial hyperglycemia 
triggers hyperinsulinemia[66]. Hyperinsulinemia is a higher-than-normal blood insulin 
concentration, and is linked to the development of coronary heart disease[67–69]. 
Central CV 
The acute effects of consuming a high glycemic meal are harmful on local 
cardiovascular components. However, the acute effects of a high glycemic index meal on 
central cardiovascular measures are unclear. It is known that chronically, high GI meals 
contribute to CVD[47,50,70,71]. It has been shown that chronic postprandial hyperglycemia, a 
 9 
direct result from consumption of a high GI meal, doubles the risk for cardiovascular 
mortality[15]. Since chronic consumption of high GI meals significantly contribute to CVD risk 
and mortality, the acute response in the central CV system should be studied in order to identify 
potential mechanisms to link acute response to chronic disease. 
 
Figure 1. The proposed mechanism for the individual and combined effects of prolonged sitting 
and high GI meal on the cardiovascular system 
Prolonged Sitting
No muscular contraction (muscle 
pump) to facilitate venous return
Blood pooling in lower extremeties
Decreased central blood volume & 
reduced blood flow to lower limbs






Beta cells of pancrease secrete 
insulin
Lack of muscle pump reduces 
glucose uptake & insulin induces 
vasodilation
Sustained hyperglycemia; mainly in 
lower limb tissues due to lack of 
venous return via muscle pump
Signal to Beta cells of pancreas to 
secrete a greater amount of insulin
Increased blood flow to tissues via 
insulin-mediated vasodilation
Greater hypoglycemia response
Greater circulating insulin and 
glucose due to lack of uptake via 
muscles
Oxidative stress




Beta cells of pancreas secrete insulin
Decreased blood glucose 
(hypoglycemia) & insulin-mediated 
vasodilation
Rapid changes in blood glucose and 
insulin levels lead to endothelial 
dysfuncion
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IMPLICATIONS/WHY IS THIS STUDY NEEDED? 
It is known that both prolonged sitting and consumption of a high GI meal have acute 
negative effects on local cardiovascular measures. However, it is unknown how these two 
stimuli interact and what their combined effect on local vasculature is, and it is unknown how the 
central cardiovascular system is affected as a result. Currently, no studies have observed the 
effects of a high GI meal and prolonged sitting on the cardiovascular system in young, healthy 
adults. If this gap in knowledge is elucidated, it will contribute to the larger picture of how 
sedentary behavior interacts with other lifestyle factors and how healthy adults are affected. 
This will either lead to the need for research of strategies to reduce the dose of sedentary 
behavior and high GI consumption, or a need for greater understanding surrounding the specific 
positive contributions healthy lifestyle choices have on “protecting” against these stimuli. 
METHODOLOGICAL CONSIDERATIONS 
The following section will outline proposed methodology in order to test the proposed 
mechanism. To date, there has been no research looking into the effects of prolonged sitting 
and consumption of a high glycemic index meal on the local and central cardiovascular 
measures. Two major considerations in the study design were external validity and internal 
validity. External validity refers to the extent to which study results can be generalized to a 
population. Internal validity refers to how well a study controlled for confounding variables, and 
allows a cause-effect relationship to be established. The appropriate participants and study 
design were used to control external validity, and the appropriate instrumentation was used to 
control internal validity. 
STUDY DESIGN CONSIDERATIONS 
The gold standard study design for research design is a randomized controlled trial. 
However, this study design would require participants to be divided into two groups and there 
may be confounding variables between the two groups. A cross-sectional study design could 
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also be appropriate, but we would not be able to deem causality, so it is not the most optimal. 
Therefore, the best study design for the desired outcome was a double-blind randomized 
crossover design with two experimental conditions (L-GI and H-GI) and the primary outcome 
being central cardiovascular health via aortic pulse velocity (PWV). A crossover design allows 
participants to act as their own control, which reduces the chance for confounders. 
MEASUREMENT CONSIDERATIONS 
Vascular Function 
Vascular health can be measured using endothelial function, central blood pressure, 
pulse wave analysis, and arterial stiffness. Endothelial function can be measured using 
ultrasound flow mediated dilation (FMD) of the brachial artery, but this requires a highly trained 
ultrasound technician. Additionally, previous research has found that prolonged sitting plays a 
role in the impairments of lower limb vascular health (via arterial stiffness), but it does not 
translate to brachial FMD[3,22,72]. Therefore, measuring endothelial function is not feasible for 
this experimental design.  
Arterial stiffness (AS) is a common measurement for vascular health, and more feasible 
than other measures. AS is directly related to cardiovascular disease risk[73]. Several methods 
have been introduced to assess AS including pulse wave velocity (PWV), ultrasound-derived 
indicators, pulse pressure, MRI-derived indicators, and pulse wave analysis (PWA)[73,74]. The 
gold standard measurement for AS is carotid-femoral PWV[75–77]. PWV can be assessed with 
applanation tonometry, the gold standard, using the PulsePen, the SphygmoCor device, or the 
Complior device [78,79],  as well as ultrasound, MRI, or the Vicorder device. The vicorder 
device (SMT Medical), has been shown to be a valid and reliable measure of PWV [78–82]. Like 
the other measures, the vicorder is a non-invasive assessment of PWV. However, the vicorder 
is less intrusive and requires very little operator training[80]. The Vicorder device is able to 
measure central aortic Pulse Wave Velocity (PWVa). Arterial stiffness and AIx are independent 
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risk factors for coronary artery disease [83]. PWA is a reliable and valid measure for arterial 
stiffness and endothelial function [77,84,85]. According to Vlachopoulos et al., a >1 m/s change 
in PWV correlated to a 14% increase in CV events, 15% increase in CV mortality, and a 15% 
increase in all-cause mortality[86]. Similarly, a 10% increase of Aix correlated to a 32% increase 
in CV mortality, and a 38% increase in all-cause mortality[86]. 
Blood Pooling 
Throughout a bout of sitting, blood pools in the lower limbs. It is necessary to measure 
this pooling to ensure we are getting the predicted response from sitting, as well as be able to 
contextualize pooling among the other vascular responses. As time spent sitting increases, 
hemoglobin is expected to rise. Previous work from this lab showed a 24% increase in tHb from 
10 to 90 minutes of sitting in a young, sedentary population[121]. Blood pooling in the calf was 
measured by looking at tissue perfusion assessed using near infrared spectroscopy (NIRS) 
(PortaMon, Artinis, Medical Systems). NIRS is a reliable and valid method for assessing tissue 
perfusion [89]. A NIRS probe was placed on the medial gastrocnemius of the right leg to 
determine the total amount of hemoglobin, as well as oxygenated and deoxygenated, in the 
tissue directly underneath. 
Blood Glucose 
Blood glucose was assessed as dependent measures of the metabolic system. The two 
methods for measuring blood glucose levels are a finger prick or venous draw and testing via a 
glucometer, or a continuous glucose monitor (CGM). Using a glucometer will allow blood 
glucose levels to be attained immediately, whereas most CGMs require information to be 
downloaded to a computer before viewing. However, using a CGM allows continuous readings 
of blood glucose levels, whereas a finger prick reading from a glucometer only provides a one-
time reading. Using a CGM will enable us to find potential trends in glucose levels. A continuous 
glucose monitor (iPro2, Medtronics) was used throughout the protocol on each experimental 
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day to measure real-time interstitial glucose. The CGM provided relevant information on hyper 
and hypoglycemia, as well as glucose variability [88]. 
Meal Intervention 
The literature was searched extensively to determine the most appropriate high and low 
GI beverage choices. This is represented in Table 1. Most studies matched for macronutrient 
content and the average low GI used was ~36 and the high GI ~80 [16,49,51,93–104]. 
Table 1. Low and High GI meals used in literature 
Author Low GI meal GI High GI meal GI Matched 
Kaviani 2016 
Boiled lentils, tomato 
sauce and Canola oil 
26 
Instant mashed potato, egg whites 




Ludwig 1999 Veggie omelet & fruit 
N/
A 
Instant oatmeal with sweetener 
(glucose plus artificial sweetener) + 
milk treated with 2 drops of lactase 


















500 mL of glucose OR 96g of 








milk, apple and peaches 
47 
Cornflakes, skimmed milk, white 






Little 2010 Lentils 26 
Instant mashed potato, egg whites 





All Bran cereal, fat-free 
strawberry yogurt, grape 
juice, multi-grain bread, 
margarine, and apple 
28 
Corn flake cereal, whole milk, 
sports drink (high carbohydrate, 
water, and electrolytes 







Dried apricots 30 White bread with strawberry jam 70 
1.5 g of 
carbohydrat
e per 1 kg of 
body mass 
Keller 2016 37 g isomaltulose 32 28g maltodextrin + 9g sucrose 90 N/A 
Kaplan 2000 
300 mL lemon beverage 
(290 mL water and 10 mL 
lemon juice) sweetened 
with 23.7 mg sodium 
saccharin) (Hermesetas 




Glucose: 300 mL lemon beverage 
(290 mL water and 10 mL lemon 
juice) containing 50 g glucose 
(Dextrose monohydrate; Bio-






Glucose solution (50 g 
glucose suspended in 450 
ml water): divided into 6 
portions over 150minutes 
N/
A 
Glucose solution (50 g glucose 
suspended in 450 ml water): 










Bran flakes cereal, semi-
skimmed milk, water 
30 









379 ml Apple & Cherry 
Juice, a commercially 
available preservative-free 
fruit juice (Wild about Fruit 
Company Pty Ltd, 
Wandin, Victoria, 
Australia; (Foster-Powell 
et al. 2002)) 
43 
50g glucose, 359mL water & 20 ml 
bottled lemon squeeze (Berri Ltd, 
Victoria, Australia; 99·9% lemon 







 Research participants were young adults (18-35), free of disease and similar in physical 
activity participation status (>90 minutes/week of moderate-vigorous exercise). A young, healthy 
population avoids the potential for age-related cardiovascular impairments. Using young 
subjects minimizes potential confounding variables, since younger people are typically healthier. 
This increases the internal validity of the study and allow for more direct conclusions to be 
inferred from our sample. An active sample (>90 minutes/week of moderate-vigorous exercise) 
was used to induce a greater effect from prolonged sitting since subjects are adapted to regular 
physical activity. This is considered due to a previous study from our laboratory (unpublished), 
and lack of major findings from sedentary subjects. Ideally a generalizable sample would be 
used, but practically, especially at this early stage, it is more feasible to recruit a homogenous 
group. Special considerations for female participants were accounted for such that they were 
tested during the first 7-10 days of the follicular phase of the menstrual cycle when hormone 
levels are relatively constant in comparison to the luteal phase. In order for both testing days to 
occur during this timeframe, we scheduled female participants so that their first experimental 
visit occurred at start of the menstrual cycle, and their second visit was toward the middle or end 





The independent variables for the study were time (pre, 10, 90, 170, post) and high or 
low GI intervention. The main dependent variables were PWV, AIx, and TSI%. Potential 
covariates for PWV was MAP, and accelerometer fidgeting data was a covariate for blood 
pooling data. For this study, a repeated measures analysis was performed. First, we considered 
a multivariate test, but with many time points for assessing PWV, it is risky to run a multivariate 
approach. This is because if a subject is missing one time point, they will be dropped from the 
entire analysis through listwise deletion. However, we wanted a statistical test that will only drop 
that one time point. Thus, we considered use of a mixed linear model. A mixed linear model 
handles repeated measures and missing data (by dropping that one missing time point). 
Additionally, we recognized that many subjects will start at different intercepts. The best 
statistical test that can handle these considerations is a mixed linear model. T-tests were 
performed to compare across time points or condition for all variables. 
OTHER CONSIDERATIONS 
Sex As A Biological Factor 
Men and women have different trajectories for acquisition of CVD risk factors over the 
course of a lifetime. We are not adequately powered to draw sex-specific conclusions from 
these results. However, the sexes can be stratified for sensitivity analysis. 
Ethnicity/Race 
While this study attempted to recruit a racially diverse sample, this study was not 
adequately powered to determine whether there were race/ethnicity and cardiovascular 






We were not able to generalize our results, as we selected a homogenous sample in 
order to minimize confounding variables. However, we would be able to apply our results to 
young, healthy, active individuals. 
Potential Challenges & Alternative Strategies 
As with any research study, there may be challenges with proper functioning of 
equipment and recruitment of participants. For 1+ year prior to commencement of data 
collection, all research assistants involved became well versed with the usage of laboratory 
equipment. Additionally, all channels of media were used to recruit participants in an attempt to 
complete scheduling in advance of data collection commencement.  
 Since sensitive cardiovascular and metabolic measures were taken in this study, 
participation in exercise should be controlled. Current literature is inconsistent, but was 
summarized to find that most pre-testing guidelines included a 24-hour refrain from exercise. 
Therefore, this approach was taken for this study.  
SUMMARY 
It is known that both prolonged sitting and consumption of a high GI meal have acute 
negative effects on local cardiovascular structure and function. However, it is unknown how 
these two stimuli interact and what their combined effect on central and local vasculature in 
young health adults. Currently, no studies have observed the effects of a high GI meal and 
prolonged sitting on the cardiovascular system in young healthy individuals. 
As previously stated, prolonged sitting acutely elicits decreased blood flow to the legs, 
decreased leg vascular shear stress, impaired vasodilator abilities, impaired endothelial 
function, and increased arterial stiffness. Based on the literature, these effects last until sitting is 
interrupted with activity [4]. Consumption of a high GI meal acutely elicits endothelial 
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dysfunction, oxidative stress, and hyperinsulinemia. The response of the combined stimuli is 
unknown, but the predicted response is augmented arterial stiffness and vascular dysfunction.  
The sample population of interest was primarily composed of college students and 
employees with desk jobs. Due to the nature of their environment, they are exposed to large 
amounts of prolonged sitting and Western diet choices. Understanding how these stimuli may 
be effecting this population is necessary to piece together chronic disease that develops later in 
life, most likely from these behaviors. This study aimed to provide clarity to the ability of young 
health individuals to respond to these stressors, and potential mechanisms for future chronic 
disease development. What aspect of repeat acute exposure to these stressors is leading to 







CHAPTER III: METHODOLOGY 
 
This study is reported in accordance with CONSORT (Consolidated Standards of 
Reporting Trials) guidelines. Ethical approval was obtained from the University of North Carolina 
at Chapel Hill institutional review board, and all participants provided written informed consent 
prior to participating in the study. 
PARTICIPANTS 
Participants were recruited from the University of North Carolina at Chapel Hill and the 
surrounding area and screened prior to enrollment in the study. Recruitment took place between 
October and February. Testing took place between November and March. Twenty participants, 
between 18 and 35 years old, were identified and scheduled for participation.  Exclusion criteria 
included: less than 90 minutes of structured exercise per week, any known cardio-metabolic 
disorders, pregnant women, smokers, currently taking medication known to affect 
cardiovascular function. Healthy, moderately active individuals were recruited to ensure a 
homogenous sample size and enhance the internal validity of the study. Participants signed an 
informed consent form prior to participation in the study. 
EXPERIMENTAL DESIGN 
This study was a double-blinded randomized crossover design with two experimental 
conditions: consumption of a low glycemic index beverage (LGI) and consumption of a high 
glycemic index beverage (HGI) preceded by a familiarization session. Both conditions were 
matched with a 3-hour period of sitting. Three hours was chosen based on previous studies 
[4,22,90,91]. Additionally, the peak postprandial glucose concentration time is estimated to be 
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~2 hours post-meal consumption[92]. Three hours ensures that we capture the peak 
postprandial glucose response. Testing began between 6:00 and 10:00 AM in the 
Cardiometabolic Lab. Refer to figure 1 for a complete overview of the study design. 
 
 




Participants reported to the Cardiometabolic Lab 12-24 hours prior to their first 
experimental day. Upon arrival, they signed the informed consent document and completed a 
medical history questionnaire. Subsequently, height, via stadiometer (Perspective Enterprises, 
Portage, Michigan), and weight, via calibrated scale (Health o meter; Pelstar LLC, McCook, IL) 
were measured. Participants were then given a food log for them to complete for the 24 hours 
leading up to each experimental day. Each participant was fitted with an accelerometer 
(ActiSleep +; ActiGraph LLC, Fort Walton Beach, FL) on their right ankle to covary for 
spontaneous movement during the subsequent experimental visit as well as ensure abstinence 
from exercise 24h prior to the experimental visits. The accelerometer was worn until their 
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completion of the study. A continuous glucose monitor (iPro2, Medtronic, Northridge CA) was 
then inserted into the participant’s site of choice: abdomen (approximately 5cm lateral from the 
umbilicus), lower back above left or right hip, or the posterior side of the upper arm. The 
continuous glucose monitor (CGM) was worn 12-24 hours prior to the first experimental day until 
their completion of the study. Participants were instructed to perform a finger prick to calibrate 
the CGM one hour after leaving the lab and once before bed (glucometer: Contour Next One; 
Ascensia Diabetes Care US Inc., Parsippany, NJ). Before leaving, the participant was given a 
pre-determined frozen meal to be consumed 12 hours prior to their experimental visits (Lean 
Cuisine; Nestle, Vevey, Switzerland). 
Visit 2 and 3 
Participants arrived to the Cardiometabolic lab (22.36 ±2°C, 26.09 ± 8.94% humidity) 
between 6:00 and 10:00 AM, with 2-7 days between experimental visits. Participants arrived 
overnight fasted from food, alcohol, and caffeine (at least 12 hours) and having abstained from 
exercise for at least 24 hours prior to the visit. Upon arrival, height and weight were recorded 
and a finger prick was performed followed by 20 minutes of quiet rest in the supine position. 
During the 20 minute rest, the participant was fitted with a NIRS probe on the medial 
gastrocnemius of the right leg, 3-lead ECG, a non-invasive blood pressure device (NIBP; 
ADInstruments) and the Vicorder device. After 20 minutes, baseline measurements were 
attained in the supine position. ECG and NIRS data were collected continuously until the 
completion of the study visit. Vicorder measurements were taken in triplicate: brachial blood 
pressure, central PWA, carotid-femoral PWV, brachial-femoral PWV, brachial-ankle PWV, and 
femoral-ankle PWV.  
After baseline measurements were obtained, the participants were passively transferred 
to a seated position (Armedica AM353 Hi-lo Treatment Table; Tiger Medical, TIGER#TM83695). 
The chair height and angle were measured and recorded to match for the second experimental 
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visit. Following re-positioning, participants were allotted 10 minutes to consume either a high GI 
(glucose; GI: 100) or low GI (fructose; GI: 19) beverage (1g/kg BW + 300mL water) flavored 
with lemon juice ad libitum. The 3-hour sitting protocol commenced following the consumption of 
the beverage [4,22,90,91]. During the 3 hours, participants were asked to sit completely still 
while watching a low stimulus documentary (pre-screened by EK and KB). PWV and PWA 
measurements were recorded in triplicate at 10, 90, and 170 minutes. After 3 hours (180 
minutes) of sitting, the participants were passively transferred to the supine position and PWV 
and PWA was reassessed after 10 minutes of rest. Blood volume may change throughout the 
course of the sitting protocol due to filtration of the blood in the kidneys and insensible water 
loss through perspiration and respiration. This may cause between 100-250 ml of water loss in a 
period of 3 hours. For this purpose, water intake was monitored during both testing sessions. In 
addition, participants were instructed to refrain from using the restroom during the study 
because standing and walking to the restroom would alter CV mechanisms. There were no 
instances of participants getting up to use the restroom at any point during the study.  
EXPERIMENTAL MEASURES 
Primary And Secondary Outcome: Central And Peripheral PWV 
Central arterial stiffness was assessed by measuring carotid-femoral and brachial-
femoral PWV using the Vicorder device (SMT Medical), and lower limb arterial stiffness was 
assessed via femoral-ankle PWV. The Vicorder device, has been shown to be a valid and 
reliable measure of PWV [78–82]. The Vicorder device is able to measure PWA and central 
aortic Pulse Wave Velocity (PWVa), a measure of arterial stiffness, which is an independent risk 
factor for coronary artery disease [83]. PWA is a reliable and valid measure for arterial stiffness 
and endothelial function [77,84,85]. According to Vlachopoulos et al., a >1 m/s change in 
carotid-femoral PWV correlated to a 14% increase in CV events, 15% increase in CV mortality, 
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and a 15% increase in all-cause mortality[86]. A clinically meaningful change for the lower limb 
is currently unknown. 
Blood pressure cuffs were placed on the dominant arm, upper thigh, and ankle for PWV 
and PWA measurements. The bottom of each cuff was marked with a permanent marker on the 
skin in the event of cuff movement. A specialized device was used to measure the distance for 
PWV measurements: all measurements were recorded in cm. For carotid-femoral PWV, the 
distance was measured from the sternal notch to the top of the femoral cuff. An additional 2.5cm 
was added to the distance to represent the distance as if measured to the middle of the cuff 
(this was to decrease measurement error as the middle of the cuff in not marked and would be 
difficult to guess by simply looking). For femoral-ankle PWV, the distance was measured from 
the top of the femoral cuff to the top of the ankle cuff. For brachial-ankle PWV, the distance from 
the top of the brachial cuff to the top of the ankle cuff was measured. When transferred to a 
seated position, all cuffs were checked to ensure exact placement remained from the supine 
position. All PWV and PWA measurements were taken in triplicate in the supine position and 
repeated at minute 10, minute 90, and minute 170 of the sitting protocol. When the participant 
was transferred to the supine position after 180 minutes, PWV and PWA measurements were 
repeated following a 10-minute supine rest. 
Control Measures 
ECG, NIBP, NIRS, and the continuous glucose monitor (CGM) collected measurements 
continuously throughout the three hours. ECG and NIBP measures allowed for continuous 
monitoring of hemodynamics. NIRS was used in order to assess blood pooling in the calf 
because this is the site for blood pooling and the gastrocnemius has been shown to be as 
sensitive as the soleus[125]. The CGM, which had been inserted 12-24 hours prior, was 
checked for proper adherence to the skin. Glucose data was extracted from the CGM and AUC 
and glucose variability were calculated (variability = highest glucose value – lowest glucose 
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value for each subject over 3 hours). For NIRS placement, the participant was asked to perform 
a calf raise in order for the researcher to identify the largest muscle belly circumference of the 
right medial gastrocnemius. This place was marked and ultrasound was used to find the thickest 
muscle belly with no large vasculature for the placement of a NIRS probe. The placement was 
measured from the popliteal fossa to the heel to ensure the same placement for the second 
visit. The NIRS probe was secured to the skin with double-sided tape and a light shield. SRS 
tHb and TSI% data were extracted from the NIRS output. NIRS SRS tHb is a validated estimate 
of total hemoglobin under the area of interest[125]. A 3-lead ECG was then attached to the 
participant at the right arm, left arm, and left lower sites. The pointer and middle fingers of the 
non-dominant hand were then measured to determine sizing for proper finger cuffs for the non-
invasive blood pressure (NIBP) device. The cuffs were secured on the middle phalanx and 
attached to the NIBP wrist unit. The device was set to sample for alternating 30 minute periods 
on each cuff, beginning with the pointer finger. This was to diminish the discomfort for the 
participant. Although NIBP data was collected continuously over the 3 hours, 30 second 
averages were taken at each time point of interest for analysis purposes. 
RANDOMIZATION  
Using online randomization software (www.randomizer.org) participants were 
randomized into either CON or GI intervention for the first visit. The randomization for all 
participants was performed prior to the first participant visit of the study and referred back to 
prior to each participant’s familiarization session. Prior to the enrollment of the first participant, 
the high and low GI solutions were covered and marked as “A” and “B” by an unaffiliated 
research assistant. The blinding was not revealed until all statistical analysis was completed at 





 Calculations to determine minimum sample size were based on the primary central 
vascular health outcome, aortic pulse wave velocity (PWV). Previous research has reported that 
prolonged sitting reduces lower limb vascular health and endothelial function between 57-
80%[25]. Based on a PWV of 6.2 m/s, which was predicted for healthy participants <30 y[105], a 
57% decrease in PWV would be 3.5 m/s. For the current study, we opted to sample based on a 
conservative change score of 1 m/s. We also used a conservative usual error of 1 m/s. Using 
magnitude-based inference, to estimate the sample size required to detect the smallest 
detrimental (or beneficial) effect in a cross-over study, with the maximum chances of a type 1 
and 2 error set at 5% (i.e. very unlikely), approximately seventeen participants were required. In 
order to account for drop out or missing data, twenty participants were recruited for the study. 
Participants were recruited from undergraduate classes at UNC as well as through email, flyer 
posting, and word of mouth. In order to improve adherence to intervention protocols, specifically 
the pre-testing guidelines, we informed the participant that the accelerometer and CGM would 
provide information concerning all activity and food/beverage consumption. 
QUALITY CONTROL 
At the conclusion of the study a random selection of 10% of the Vicorder data sets (e.g. 
from 3 participants) were re-entered by an independent observer. No data points differed, so no 
further action was taken. 
DATA MANAGEMENT AND STATISTICAL ANALYSIS 
Data sheets were stored in a locked drawer and in digital form on two study computers. 
All statistical analyses were performed using Jamovi (2018, Version 0.9). The α level was set a 
priori for all statistical procedures at α=0.05. Raw data are presented as mean [standard 
deviation] and mixed model data are presented as mean [95% confidence interval]. Supine (Pre 
vs. Post) and sitting (min 10, 70 and 170) date were analyzed separately.  
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Continuous glucose data was averaged over time and analyzed using a paired samples 
t-test. Glucose AUC and variability was also calculated to compare to PWV variability using a 
Pearson’s R correlation. For all other outcomes, the effects of time (pre vs. post and 10 vs. 90 
vs. 170) and condition (A vs. B) were analyzed using linear mixed models with fixed effects of 
condition and random effect of time and participant. Using a mixed model is appropriate given 
the correlated data (repeated measures) with various distributional assumptions and its ability to 
accommodate missing data. A condition-by-time interaction term was included in regression 
models to examine between condition differences across time points. All models were adjusted 
for baseline values. PWV outcomes were adjusted for baseline values and MAP, as MAP is a 
confounder of PWV. Effect sizes were calculated as Cohen’s d, where <0.20 is considered to be 
a small, > 0.20 to < 0.50 a moderate, and > 0.60 a large effect. For the mixed models Cohen’s d 
was calculated as the effect of condition (β) or time (β) from linear mixed models divided by the 







CHAPTER IV: RESULTS 
 
PARTICIPANTS 
Participants were young (23 ± 3 years), moderately active (280 ± 175 minutes/week), 
normal height and weight (172.6 ± 8.7 cm; 72.8 ± 15 kg; BMI: 24.3 ± 3.7 kg/m2), and otherwise 
healthy men and women (33% female). Participants self-identified as Caucasian (n=14), African 
American (n=2), and Middle-Eastern (n=4). All participants conformed to pretesting guidelines. 
Participant characteristics are illustrated in table 2. 
 Eighteen of the twenty participants completed the study and were used for analysis. 
Figure 3 illustrates the CONSORT diagram for participant recruitment and drop out. All data was 
collected and analyzed successfully apart from two missing data points from NIRS in the LGI 






































Figure 3. CONSORT diagram. NIRS: near infrared spectroscopy 
 
BASELINE DATA 
Baseline data is reported in Table 2. There were no significant differences in baseline 
hemodynamic measures between testing days (table 2). Baseline tHb data are not reported as 
values as they are expressed relative to baseline. In order to achieve the most precise results, 
baseline measures were set as covariates when analyzing all supine primary, secondary, and 
ancillary measures. Adherence to pre-assessment guidelines were confirmed through 
accelerometer and blood glucose data. There was no significant difference between total MVPA 
(moderate-vigorous physical activity) during the 12-24 hours prior to experimental visits (HGI: 
42.2, LGI: 52.4 minutes, p=0.079). Additionally, the AUC for blood glucose data 12 hours prior 









Total drop-outs n=2 
Potential participants emailed 
(n=1500) 




Table 2. Participant Characteristics and Hemodynamic Measures at Baseline (mean ± SD) 
Variable Total LGI HGI P value (effect size) 
HR (BPM) 
 
58.51 ± 10.68 58.47 ± 11.55 0.972 (0.004) 
MAP (mmHg) 
 
83.56 ± 9.44 82.41 ± 7.97 0.535 (0.131) 
DBP (mmHg) 
 
58.39 ± 5.65 57.92 ± 5.36 0.647 (0.086) 
SBP (mmHg) 
 
121.72 ± 12.20 122.12 ± 9.89 0.814 (-0.036) 
PP (mmHg) 
 
63.33 ± 9.35 64.26 ± 7.65 0.609 (-0.109) 
cSBP (mmHg) 
 
114.81 ± 12.73 114.03 ± 8.34 0.934 (0.072) 
cPP (mmHg) 
 
55.86 ± 9.68 56.91 ± 6.65 0.392 (-0.127) 
pp/cPP (mmHg) 
 
1.14 ± 0.10 1.05 ± 0.29 0.239 (0.404) 
AIx (%) 
 
11.36 ± 5.11 11.83 ± 6.20 0.740 (-0.083) 
SEVR (%) 
 
179.94 ± 47.99 170.91 ± 33.69 0.380 (0.218) 
SV (mL) 
 
57.28 ± 8.82 56.97 ± 15.42 0.651 (0.024) 
CO (L/min) 
 
3.49 ± 0.84 3.56 ± 1.19 0.918 (-0.074) 
TPR (PRU) 
 
3.76 ± 0.99 4.00 ± 1.33 0.413 (-0.211) 
 
PA: physical activity; HR: heart rate; MAP: mean arterial pressure; DBP: diastolic blood 
pressure; SBP: systolic blood pressure; PP: pulse pressure; cSBP: central systolic blood 
pressure; cPP: central pulse pressure; pp/cPP: pulse pressure/central pulse pressure; AIx: 
augmentation index; SEVR: subendocardial viability ratio; SV: stroke volume; CO: cardiac 




STIMULUS: CONTINUOUS BLOOD GLUCOSE 
Figure 4 illustrates the average blood glucose (mg/dL) across the three hours between 
the conditions. Overall, HGI had a higher average value (107 ± 19 mg/dL) compared to LGI (92 
± 4 mg/dL), and a larger area under the curve (AUC) (19429 ± 98) than LGI (16498 ± 19). For 
average values, there was a large significant effect (p<0.001, d=0.983). Additionally, for AUC 
values, there was a large significant effect (p<0.001, d=1.01). Across the 3-hour postprandial 
period, the highest glucose value observed was 98.76 mg/dL for the LGI condition and 138.94 
mg/dL for the HGI condition. The lowest glucose value observed was 86.76 mg/dL for the LGI 
condition and 78.5 mg/dL for the HGI condition. Average glucose variability was 71.56 ± 26.60 
mg/dL for the HGI condition and 28.71 ± 19.72 mg/dL for the LGI condition. 
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Figure 4. Average blood glucose response to high and low GI beverage for all subjects over 3 
hours of sitting 
 
PRIMARY OUTCOME: CENTRAL PULSE WAVE VELOCITY 
There was no significant time x condition interaction for central (carotid-femoral) PWV in 
the supine position (table 3). However, there was a significant time x condition interaction for 
bfPWV (p=0.027) (figure 5). PWV increased by 0.27 m/s in the LGI condition (95% CI: 0.2517, 
0.669) and 0.45 m/s in the HGI condition (95% CI: 0.068, 0.485). 
  
Figure 5. Mean brachial-femoral PWV supine measurements before and after three hours of 
uninterrupted sitting (bars represent SD). bfPWV: brachial-femoral pulse wave velocity; HGI: 









































Table 3. Supine Arterial Stiffness Measures 
    cfPWV bfPWV faPWV 
Time Condition   m/s m/s m/s 
Pre HGI X 6.08 8.63 6.75 
    SD 0.95 0.66 0.83 
  LGI X 6.11 9.00 6.96 
    SD 1.08 0.75 0.77 
Post HGI X 6.13 9.08 7.13 
    SD 0.97 0.63 1.11 
  LGI X 5.98 9.27 7.67 
    SD 1.24 0.95 1.15 
Interaction   P 0.223 0.027 0.178 
Time   P 0.628 0.001 0.004 
    ES -0.060 0.470 0.380 
Condition   P 0.254 0.078 0.180 
    ES -0.190 -0.300 0.230 
cfPWV: carotid-femoral pulse wave velocity; bfPWV: brachial-femoral pulse wave 
velocity; faPWV: femoral-ankle pulse wave velocity; HGI: high glycemic index; LGI: low 
glycemic index 
 
SECONDARY OUTCOME: PERIPHERAL PWV 
There was no significant time x condition interaction for lower limb (femoral-ankle) PWV 
in the supine (Table 2) or seated position. However, there was a significant effect for time 
(p=0.004, d=0.38; 95% CI: 0.219, 0.897) in the supine condition (figure 6). 
 
 
Figure 6. Mean femoral-ankle PWV supine measurements before and after three hours of 
uninterrupted sitting (bars represent SD). faPWV: femoral-ankle pulse wave velocity; HGI: high 





















There were no significant interaction or condition effects for AIx or cSBP. There was a 
significant time effect for augmentation index (AIx). AIx decreased by 2.93% (p=0.02, d=-0.32; 
95% CI: -5.05, -0.814) in the supine position (table 4).  
  Table 4. Hemodynamic measures and NIRS output. cSBP: central systolic blood pressure; 
Aix: augmentation index; CO: cardiac output; TPR: total peripheral resistance; PRU: peripheral 
resistance units; HR: heart rate; BPM: beats per minute; SRS tHb: spatially resolved 
spectroscopy total hemoglobin; TSI: tissue saturation index; HGI: high glycemic index; LGI: low 
glycemic index 
      cSBP AIx CO TPR HR SRS tHb TSI 
      mm Hg % L PRU BPM mm % 
Pre HGI X 114.03 11.83 3.56 4.00 61.70 49.61 57.98 
    SD 8.34 6.20 1.19 1.33 11.51 22.94 54.41 
  LGI X 114.81 11.36 3.49 3.76 60.71 56.84 58.68 
    SD 12.73 5.11 1.19 1.33 11.51 22.94 54.41 
Post HGI X 112.69 8.58 3.62 3.85 61.74 52.16 52.29 
    SD 8.22 4.52 1.00 1.17 11.58 16.36 52.96 
  LGI X 114.72 8.75 3.68 3.90 68.75 55.92 58.09 
    SD 10.90 3.21 0.89 0.89 16.20 20.66 51.29 
Interaction   P 0.615 0.710 0.710 0.421 0.050 0.586 0.226 
Time   P 0.581 0.015 0.501 0.976 1.000 0.818 0.138 
    ES -0.066 -0.320 0.120 -0.005 0.308 0.028 -0.179 
Condition   P 0.387 0.859 0.982 0.644 0.233 0.074 0.123 
    ES 0.148 -0.030 0.006 -0.116 0.304 0.305 0.262 
 
There were no significant condition x time interaction effects or time effects in the NIRS output. 
There were significant condition effects for SRS tHb (p=0.02), and TSI% (p=0.001) (table 4).  
SUPPLEMENTAL ANALYSIS 
All measures made in the seated position (10, 90, 170 minutes) are included in Appendix 
B. In the seated position, there was a significant condition effect for MAP (p=0.001, d=0.71), 
DBP (p=0.001, d=0.73), and SBP (p=0.001, d=0.86), taken from the NIBP device, with all values 
being greater in the HGI condition. There was a significant condition effect for SV (p=0.001, d=-
1.35), CO (p=0.001, d=-1.07), and TPR (p=0.001, d=-0.94) (appendix B). There was no 
correlation between glucose and changes in bfPWV (r=0.205, p=0.238; 95% CI: 0.504, -0.138), 
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and a weak-moderate correlation between glucose variability and changes in bfPWV (r=0.400, 
p=0.017; 95% CI: 0.647, 0.077) (figure 7).  
    
 
Figure 7. Correlation between glucose variability bfPWV (A) and glucose AUC and 
bfPWV (B). AUC: area under the curve; HGI: high glycemic index; LGI: low glycemic index 
  






















































CHAPTER V: DISCUSSION 
 
The purpose of this study was to examine the peripheral and central cardiovascular 
response to prolonged sitting following the consumption of a low and high GI meal. It was 
hypothesized that prolonged sitting and the consumption of a high GI meal would elicit greater 
detriments in both central and peripheral PWV. The expected glucose stimulus was achieved, 
with the LGI meal eliciting a small, gradual increase in blood glucose, and the HGI meal eliciting 
a large increase in blood glucose for ~30 minutes following consumption. Prolonged sitting (3 
hours) and consumption of a high GI beverage increased central (brachial-femoral) arterial 
stiffness, with a slightly greater detriment in the HGI condition. However, carotid-femoral PWV 
was not influenced by prolonged sitting or HGI meal consumption. Peripheral (femoral-ankle) 
PWV increased regardless of the level of GI consumed. Collectively, this data demonstrates that 
in young health adults a single bout of prolonged uninterrupted sitting combined with a high 
glycemic index beverage can negatively affect markers of central and peripheral cardiovascular 
function, but there are some inconsistencies in the findings. 
LIMITATIONS AND STRENGTHS 
To better contextualize the discussion, the limitations and strengths of the current study 
must be stated. First, our study results lack generalizability as we used a group of healthy, 
active, young adults. However, we elected to recruit a homogenous group of healthy, active, 
young adults to minimize the confounding influence of age and CVD. Although the sample was 
healthy, it is unknown how much previous exposure they had to these stimuli. Second, 
participants were all required to be active for at least 90 minutes per week, however it is 
unknown what lifestyle choices were made outside of that. Future studies should collect 
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accelerometer and food log data on participants for an extended period of time in order to 
gather more data concerning lifestyle choices. Third, we were unable to determine sex 
interactions due to being inadequately powered, but we are confident that the experimental 
conditions were well controlled in that fluctuations in estrogen in females would not affect our 
results.  
Although this study has a few limitations, it also has several strengths including the use 
of the Vicorder device. The Vicorder measures PWV and PWA in a non-intrusive manner with 
little operator training, ease of use, and low user error. This also allowed for a comprehensive 
assessment of cardiovascular measures. Second, we were adequately powered to conduct this 
study. Third, trial conditions were standardized for potential confounders such as diet, physical 
activity, and baseline values. Finally, this study is a double blind crossover design, which 
reduces bias in our results. 
COMPARISON TO LITERATURE 
This study found that prolonged sitting (3 hours) and consumption of a high GI beverage 
increased central (brachial-femoral) arterial stiffness, with a moderately (d=0.50) greater 
detriment in the HGI condition. However, carotid-femoral PWV was not influenced by prolonged 
sitting or HGI meal consumption. There was a moderate (d=0.41) increase in peripheral 
(femoral-ankle) PWV slightly regardless of the level of GI consumed. Although the results were 
not clinically significant (>1m/s), it does support the current literature[108,120-121]. That is, the 
established <1m/s clinical value is for chronic changes, repeatedly exposing the aorta to a 0.45 
m/s increase in stiffness following a high GI meal may accumulate to significant cardiovascular 
burden over time[123]. This offers an additional insight into a young, healthy person’s ability to 
respond to a high dose of sugar.  
Prolonged sitting resulted in a significant increase in central (brachial-femoral) PWV, 
with a moderately greater change (0.18 m/s) in the high GI condition. Two other studies, plus 
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one additional unpublished paper [personal communication] have reported increased central 
PWV with an acute bout of prolonged sitting [108,120]. The current study is the first to 
investigate changes in central PWV with prolonged sitting and a high glycemic index meal. The 
findings indicate that high GI consumption exacerbates the detriments from prolonged sitting, 
and should be further explored.  However, the carotid-femoral PWV was not significantly 
impacted by prolonged sitting or a high GI meal, which was predicted based on previous 
literature [3, 108]. A potential reason is that the brachial-femoral measurement incorporates the 
subclavian artery. Since the subclavian artery is slightly smaller than the aorta, it may be more 
responsive to change in a healthy population, which could explain the differences in 
measurement responses. While no studies have directly compared the reliability of brachial-
femoral PWV versus carotid-femoral PWV, it is plausible that the brachial-femoral PWV confers 
greater reliability and sensitivity. For the current study we did consistently find greater signal 
strength for the brachial-femoral measurement. The responsiveness of carotid-femoral and 
brachial-femoral PWV should be explored further to understand their reliability in this population. 
 Prolonged siting resulted in a significant increase in peripheral (femoral-ankle) PWV, 
regardless of GI beverage. These results contribute to the existing literature that prolonged 
sitting acutely impairs the structure and function of lower limb vascular health [3-4,22,25], with a 
decrease in shear stress being the proposed mechanism [22]. Shear stress has been shown to 
decrease across a bout of prolonged uninterrupted sitting due to a decrease in blood flow to the 
limb caused by blood pooling in the legs (shown by the increase in perfusion). However, in the 
current study, tHb did not increase (indicative of blood pooling) in the LGI condition. This could 
be attributed to the subjective feeling of cold many subjects experienced during the bout of 
sitting, potentially causing local vasodilation, facilitating venous return. This may not have been 
seen in the HGI condition, because HGI consumption is associated with greater insulin 
secretion, which is a vasodilator. However, the data is inconclusive in supporting this as there 
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were no significant changes in CO. The potential blood pooling is caused by lack of venous 
return due to lack of muscle pump and gravitational forces. A decrease in shear stress is 
associated with endothelial function impairment. Findings from this study, an increase in lower 
limb arterial stiffness due to sitting, are in line with current literature. Current literature assessing 
the effects of acute prolonged sitting (3-8 h) on endothelial function, using flow-mediated dilation 
(FMD), reported a 48-71% decline in leg FMD [3-4,25,72,117-119]. Impairment to the 
vasculature of the leg due to prolonged sitting is of clinical relevance since evidence supports 
that the leg vasculature is vulnerable to atherosclerosis [4]. However, consumption of a high GI 
meal did not further impair peripheral vasculature. This suggests that not all vasculature 
responds the same to the same stimulus, and this should be explores in other areas of the 
body.  
 The proposed mechanism explaining cardiovascular detriments from prolonged sitting 
begins with blood pooling in the lower limbs. This leads to a decrease in venous return, and 
therefore a decrease in cardiac output. We did not find any changes in CO throughout the 3-
hour sitting protocol, but that may be attributed to the young, healthy sample that was used. A 
decrease in CO would result in decreased pressure on baroreceptors, increasing sympathetic 
nervous system activity and therefore increasing total peripheral resistance (TPR). We did not 
find any changes in TPR throughout the protocol either, which would support the lack of change 
in CO. The theorized increase in CO and TPR would increase the central hemodynamic load on 
the cardiovascular system, explaining the pathway from peripheral to central impairments from 
prolonged sitting. Possible explanations for the lack of support for this mechanism from our 
results could be the sample chosen is better able to compensate with an adverse stimulus, or 
measurement error. It is possible that the NIBP (non invasive blood pressure) used to measure 
CO and TPR was variable based on positional placement. 
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 Prolonged sitting resulted in a significant reduction in AIx, regardless of GI beverage. AIx 
is a measure of systemic arterial stiffness derived from the ascending aortic pressure waveform 
[106]. A reduction in AIx after prolonged uninterrupted sitting could be attributed to the increase 
in blood pooling, leading to a reduction in venous return and therefore a reduction in stroke 
volume and subsequently AIx. These results have been found previously in our lab[121]. The 
results showed a slight reduction in stroke volume from minute 10 to minute 170 in the high GI 
beverage condition, but a fluctuation in stroke volume between minute 10 and 90 and minute 90 
and 170 in the low GI beverage condition. These findings suggest that AIx may not be telling us 
about vascular health during sitting, but rather autonomic function. It also suggests that the 
blood may in fact be pooling, and the NIRS measurement is not adequately reflecting this 
pooling. 
IMPLICATIONS 
Prior to this study, it was understood that prolonged sitting and high GI consumption 
have detrimental chronic and acute effects on the cardiovascular system[3-4,108]. However, it 
was unknown how the two stimuli interacted acutely to effect the central and local 
cardiovascular system. The data herein supports the interaction between prolonged sitting and 
high GI consumption and their effects on the cardiovascular system in a young, healthy 
population. There seem to be greater changes in arterial stiffness at the level of the heart rather 
than the local leg vasculature. Due to the common nature of prolonged sitting and high GI 
consumption in everyday life, particularly in offices, this information is useful and pertinent. If the 
mechanism behind acute exposure to prolonged sitting and high GI consumption and 
subsequent cardiovascular detriments are elucidated, the chronic effects leading to CVD can be 
better understood. Future studies addressing prolonged sitting and its interaction with other 
lifestyle factors on cardiovascular function are warranted, perhaps focusing on extending the 
generalizability of the finding to an actual office worker. 
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Table 5. Implications 
What did we know? 
• Chronic prolonged sitting is correlated with CVD 
• Western diet (highly composed of high GI foods/beverages) is correlated with CVD 
• Acute prolonged sitting impairs cardiovascular structure and function (central and local) 
in healthy and diseased populations 
• Acute consumption of high GI foods/beverages elicits impairments to the vasculature 
(oxidative stress) and unstable glucose/insulin response 
What did we not know? 
• Acute effects of prolonged sitting and HGI beverage on CV system in young, healthy 
adults 
What have we learned? 
• Acute prolonged sitting (3 hours) impairs lower limb vascular structure in young, 
healthy adults 
• Augmentation index is impaired over 3 hours of sitting in young, healthy adults 
• High GI beverage does not exacerbate these effects 
Why is this new information useful? 
• We now have a better understanding of how young, healthy adults respond to these 
combined stimuli 
What do we need to know next? 
• Does a larger glucose dose elicit an impaired response in this population? 
• Home or work-based studies are needed to determine these effects in a real-life 
scenario. 
• Middle-aged populations need to be observed as they are the “middle ground” between 





 The purpose of this study was to determine the effects of prolonged sitting (3 hours), 
with or without a high GI beverage, on central (carotid-femoral and brachial-femoral) and local 
(femoral-ankle) arterial stiffness in young, health adults. The findings suggest that, in this 
population, prolonged sitting does not contribute to significant detriments on central arterial 
stiffness, but it does increase local stiffness regardless of high or low glycemic index beverage 
consumption. This suggests that local detriments could impair central cardiovascular function, 
either with a larger stimulus or in less healthy population. Further studies are necessary to 
investigate the interaction between local impairments and central cardiovascular function. 
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Consent Form Version Date: _7/26/2018_____________ 
IRB Study # 17-2532 
Title of Study: Prolonged Sitting With or Without a High Glycemic Index Meal: Acute Effects 
on Vascular and Cerebrovascular Function in Healthy Adults 
Principal Investigator: Elizabeth Kelsch 
Principal Investigator Department: Exercise and Sport Science 
Principal Investigator Phone number: (919) 962-0396 
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Co-Investigators: Katie Burnet, Dr. Erik Hanson 
Faculty Advisor: Lee Stoner  
Faculty Advisor Phone Number: (919) 962-0534 




What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary. 
You may choose not to participate, or you may withdraw your consent to be in the study, for any 
reason, without penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. Deciding not to be in the study or leaving the 
study before it is done will not affect your relationship with the researcher, your health care 
provider, or the University of North Carolina-Chapel Hill. If you are a patient with an illness, 
you do not have to be in the research study in order to receive health care. 
 
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form.  You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
To examine the acute effects of sitting and consumption of a high glycemic index (HGI) meal on 
cardiovascular health, cerebrovascular health, cognition, and the proposed mechanisms within 
the body that may lead to the observed effects. Findings from this study may contribute to public 
health policy concerning sedentary behavior and the Western diet. 
 
You are being asked to be in the study because you are between the ages of 18-40 years. 
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You should not be in this study if you have a BMI greater than 30 kg/m
2
, you have known 
cardiovascular or metabolic diseases, you smoke tobacco, or you are pregnant (urine pregnancy 
test will be given). 
 
How many people will take part in this study? 
There will be approximately 20 people in this research study. 
 
How long will your part in this study last? 
Should you wish to participate in the study, you will be required to attend the Applied 
Physiology Laboratory at University of North Carolina at Chapel Hill on three occasions. The 
first visit will last approximately 30 minutes, and the following visits approximately 4 hours. 
 
What will happen if you take part in the study? 
Visit One: Participants will complete report to the UNC Applied Physiology Laboratory where 
informed consent will be obtained. Participants will be screened for participation in the study, 
which will include a medical history questionnaire. During this familiarization day, participants 
will be given a food log for them to complete for the 24 hours leading up to the first 
experimental day until their completion of the study. Each subject will be fitted with an 
accelerometer (ActiSleep +; ActiGraph LLC, Fort Walton Beach, FL) on their ankle to covary 
for spontaneous movement as well ensure abstinence from exercise 24h prior to the experimental 
visits. The accelerometer will be worn at least 24 hours prior to the first experimental day until 
their completion of the study. A continuous glucose monitor (iPro2, Medtronic, Northridge CA) 
will then be inserted into the participant’s abdomen, approximately 5cm lateral from the 
umbilicus. The continuous glucose monitor (CGM) will be worn the day prior to each 
experimental visit, until the cessation of each experimental visit. The participants will receive a 
standardized frozen meal to consume 12 hours prior to each experimental visit.  
 
Visit Two: For the first experimental visit, participants will report to the Applied Physiology 
Laboratory between 6 and 10am in rest in the supine position for 20 minutes. During supine rest, 
the participant will be fitted with near infrared spectroscopy (NIRS) devices on the prefrontal 
cortex and the medial gastrocnemius, a 3-lead electrocardiogram, the Vicorder device, and a non-
invasive blood pressure device (NIBP) on the wrist. Subsequently, cognitive function will be 
assessed using a Stroop test, Trail Making test, and a memory test; noninvasive measures of 
vascular health will be performed using the Vicorder device. The participants will then be 
passively transferred to a sitting position, where (s)he will be allotted 10 minutes to consume 
either the control (CON) or high glycemic index (HGI) beverage.  The participant will then 
remain seated for 180 minutes while watching a low-stimulus documentary. Brain and calf blood 
flow and tissue oxygenation will be monitored continuously with NIRS. After 10, 90 and 170 
minutes of sitting vascular function and cerebrovascular blood flow will be measured. The 
participants will then be passively transferred to the supine position after 180 minutes of sitting. 
Following 10 minutes of quiet rest, vascular health will be re-measured and cognitive function 
will be reassessed. If the participant needs to use the restroom, this will be recorded, and they 
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Visit Three: Participants will return for follow up testing within 10 days after visit two. The 
experimental procedures will be identical to visit 2. The participant will be randomly assigned to 
either HGI or CON for visits two and three. The beverage will be administered by an 
undergraduate research assistant to allow for double blindedness. 
 
What are the possible benefits from being in this study? 
There is no direct benefit to participants. 
 
What are the possible risks or discomforts involved from being in this study? 
While in this study, a finger prink will need to administered to obtain blood glucose levels, 
which may be uncomfortable. The insertion of a continuous glucose monitor could cause 
discomfort. A Urine Pregnancy test provided by the study will be obtained for all women of 
child-bearing potential, which could also cause some discomfort. The device we will use to 
monitor blood flowing to your calf and brain also possesses a small risk of eye damage/irritation, 
and skin heating/irritation. There may be uncommon or previously unknown risks. You should 
report any problems to the researcher. 
 
How will information about you be protected? 
Hard copies of any identifiable information will be stored in a locked file cabinet within an 
access-controlled laboratory in Fetzer Hall (Applied Physiology Lab) at the University of North 
Carolina at Chapel Hill campus. Only members of the research team will have access to the 
cabinet. Any electronic files with identifiable information will be kept separate in password-
protected files on password-protected computers that will be accessible to only members of the 
research team. Upon completion of the study, all data will be transferred to an electronic storage 
device, files will become password protected, and all hard copies will be shredded.  
Participants will not be identified in any report or publication about this study. Although every 
effort will be made to keep research records private, there may be times when federal or state law 
requires the disclosure of such records, including personal information.  This is very unlikely, 
but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by law to protect 
the privacy of personal information.  In some cases, your information in this research study could 
be reviewed by representatives of the University, research sponsors, or government agencies (for 
example, the FDA) for purposes such as quality control or safety. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have the 
right to stop your participation at any time. This could be because you have had an unexpected 
reaction, or have failed to follow instructions, or because the entire study has been stopped. 
 
Will you receive anything for being in this study? 
You will be receiving a vascular health report for taking part in this study. 
 
Will it cost you anything to be in this study? 
It will not cost you anything to be in this study.  
 
What if you are a UNC student? 
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time.  This will not affect your class standing or grades at UNC-Chapel Hill.  You will not be 
offered or receive any special consideration if you take part in this research. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions about the study, complaints, concerns, or if a research-related injury occurs, 
you should contact the researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject, or if you 
would like to obtain information or offer input, you may contact the Institutional Review Board 
at 919-966-3113 or by email to IRB_subjects@unc.edu. 
 
 
Consent Form Version Date: _8/18/2018_____________ 
IRB Study # 17-2532 
Title of Study: Prolonged Sitting With or Without a High Glycemic Index Meal: Acute Effects 
on Vascular and Cerebrovascular Function in Healthy Adults 




I have read the information provided above.  I have asked all the questions I have at this time.  I 































 APPENDIX B – ADDITIONAL TABLES 
Table 1. Seated Hemodynamic Measures 
Seated 
HR MAP DBP SBP PP cSBP cPP pp/cPP AIx SEVR SV CO TPR 
      bpm mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg % % ml L/min PRU 
HGI 
10 X 68.26 82.19 58.33 120.94 63.15 112.53 55.31 1.11 9.97 9.97 174.44 114.72 7.44 
  SD 11.84 10.28 8.31 10.52 7.47 9.99 9.66 0.29 7.18 7.18 36.52 20.47 1.93 
90 X 72.16 82.78 58.94 118.92 59.53 111.17 51.72 1.10 8.97 8.97 174.83 102.09 7.41 
  SD 12.26 7.38 7.13 10.19 10.13 8.59 8.13 0.10 5.75 5.75 41.50 17.99 2.47 
170 X 70.73 84.31 61.53 121.53 60.00 112.97 51.69 1.16 8.86 8.86 180.67 103.66 7.00 
    SD 13.55 9.31 7.63 9.61 6.90 9.42 6.50 0.29 4.12 4.12 41.60 12.28 1.75 
LGI 
10 X 69.85 86.78 63.39 125.33 61.94 117.53 54.97 1.13 8.75 8.75 189.36 112.88 7.75 
  SD 12.58 10.07 7.72 10.35 7.23 12.92 8.90 0.11 4.61 4.61 34.74 15.86 1.71 
90 X 73.80 88.83 64.22 125.17 60.94 119.67 55.33 1.11 9.64 9.64 170.19 106.41 7.69 
  SD 13.05 8.50 7.30 9.85 6.69 9.64 6.40 0.07 4.28 4.28 32.24 15.59 1.58 
170 X 72.85 85.53 62.28 125.11 62.83 115.36 52.64 1.19 10.03 10.03 169.89 102.12 7.16 
    SD 12.65 7.39 7.95 11.04 9.63 8.78 6.21 0.12 4.69 4.69 34.06 12.58 1.39 
Interaction P 0.980 0.976 0.098 0.057 0.459 0.257 0.054 0.268 0.977 0.308 0.308 0.006 0.448 
Time   P 0.015 0.516 0.603 0.474 0.282 0.609 0.099 0.217 0.985 0.985 0.168 0.002 0.190 
    ES 0.196 0.037 0.088 0.005 -0.084 -0.066 -0.212 0.127 0.008 0.008 -0.144 -0.367 -0.168 
Condition P 0.110 0.105 0.001 0.001 0.001 0.305 0.001 0.165 0.569 0.760 0.760 0.960 0.756 
    ES 0.272 0.708 0.727 0.862 0.175 0.865 0.235 0.096 0.051 0.051 -0.008 0.055 0.189 
 
HR: heart rate; MAP: mean arterial pressure; DBP: diastolic blood pressure; SBP: systolic blood pressure; PP: pulse pressure; cSBP: central 
systolic blood pressure; cPP: central pulse pressure; pp/cPP: pulse pressure/ central pulse pressure; AIx: augmentation index; SEVR: systemic 

























tHb: total hemoglobin; HbO2: oxygenated hemoglobin; HHb: deoxygenated hemoglobin; SRS tHb: spatially resolved spectroscopy total 
hemoglobin; TSI: tissue saturation index; HGI: high glycemic index; LGI: low glycemic index  
 Seated     tHb_2 tHb_3 HbO2_2 HbO2_3 HHb_2 HHb_3 SRS tHb TSI 





10 X 52.84 53.09 25.76 26.24 27.08 26.86 60.81 55.08 
  SD 56.26 62.39 31.55 36.82 25.03 25.87 29.96 51.53 
90 X 44.28 44.29 20.26 19.93 24.01 24.20 53.05 51.00 
  SD 48.54 51.49 28.39 29.42 20.42 22.01 25.61 54.02 
170 X 52.69 53.13 24.59 25.61 28.09 27.52 60.53 56.40 





10 X 40.29 42.61 17.44 18.84 22.84 23.76 54.22 50.20 
  SD 59.11 63.14 33.78 36.74 25.60 26.66 34.67 51.85 
90 X 49.46 50.43 21.89 23.41 27.56 27.02 61.22 57.27 
  SD 56.04 61.58 31.69 36.50 24.84 25.45 27.82 51.29 
170 X 38.64 41.60 16.94 18.72 21.70 22.88 55.34 48.89 
    SD 45.72 50.13 26.25 28.92 19.74 21.50 24.77 54.02 
Interaction P 0.924 0.989 0.954 0.984 0.774 0.922 0.955 0.542 
Time   P 0.638 0.851 0.459 0.802 0.857 0.915 0.919 0.981 
    ES -0.091 -0.053 -0.121 -0.064 -0.048 -0.033 0.039 0.012 
Condition   P 0.013 0.052 0.017 0.041 0.012 0.079 0.020 0.001 
    ES 0.423 0.329 0.407 0.347 0.425 0.297 0.395 0.655 
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APPENDIX C – PARTICIPANT LOGS 
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